Cargando…

A Brazilian Inter-Hospital Candidemia Outbreak Caused by Fluconazole-Resistant Candida parapsilosis in the COVID-19 Era

Horizontal transmission of fluconazole-resistant Candida parapsilosis (FRCP) through healthcare workers’ hands has contributed to the occurrence of candidemia outbreaks worldwide. Since the first COVID-19 case in Brazil was detected in early 2020, hospitals have reinforced hand hygiene and disinfect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomaz, Danilo Y., Del Negro, Gilda M. B., Ribeiro, Leidiane B., da Silva, Mirian, Carvalho, Gabrielle O. M. H., Camargo, Carlos H., de Almeida, João N., Motta, Adriana L., Siciliano, Rinaldo F., Sejas, Odeli N. E., Rossi, Flávia, Abdala, Edson, Strabelli, Tânia M. V., Benard, Gil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874954/ https://www.ncbi.nlm.nih.gov/pubmed/35205855 http://dx.doi.org/10.3390/jof8020100

Ejemplares similares

Environmental Clonal Spread of Azole-Resistant Candida parapsilosis with Erg11-Y132F Mutation Causing a Large Candidemia Outbreak in a Brazilian Cancer Referral Center
por: Thomaz, Danilo Y., et al.
Publicado: (2021)

Performance of a Real-Time PCR Assay for the Detection of Five Candida Species in Blood Samples from ICU Patients at Risk of Candidemia
por: Felix, Gabriel N., et al.
Publicado: (2023)

Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit
por: Pinhati, Henrique Marconi Sampaio, et al.
Publicado: (2016)

Impact of the COVID-19 Pandemic on the Clinical Profile of Candidemia and the Incidence of Fungemia Due to Fluconazole-Resistant Candida parapsilosis
por: Ramos-Martínez, Antonio, et al.
Publicado: (2022)

Determinants of fluconazole resistance and echinocandin tolerance in C. parapsilosis isolates causing a large clonal candidemia outbreak among COVID-19 patients in a Brazilian ICU
por: Daneshnia, Farnaz, et al.
Publicado: (2022)

Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy
por: Zhang, Li, et al.
Publicado: (2015)

Increase in Candida Parapsilosis Candidemia in Cancer Patients
por: Sun, Mingyue, et al.
Publicado: (2019)

An Azole-Resistant Candida parapsilosis Outbreak: Clonal Persistence in the Intensive Care Unit of a Brazilian Teaching Hospital
por: Thomaz, Danilo Yamamoto, et al.
Publicado: (2018)

Candida parapsilosis keratitis treated successfully with topical and oral fluconazole
por: Li, Pei-Hsuan, et al.
Publicado: (2016)

Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007
por: Poikonen, Eira, et al.
Publicado: (2010)

Candida parapsilosis Candidemia Resistance Patterns and Treatment Outcomes: An Opportunity for Antifungal Stewardship
por: Fong, Gary, et al.
Publicado: (2017)

Epidemiology and risk factors of candidemia due to Candida parapsilosis in an intensive care unit
por: Zuo, Xiao-shu, et al.
Publicado: (2021)

2885. Increased incidence of fluconazole-resistant Candida parapsilosis bloodstream infections in Atlanta, Georgia 2021
por: Witt, Lucy S, et al.
Publicado: (2023)

Determinants of fluconazole resistance and the efficacy of fluconazole and milbemycin oxim combination against Candida parapsilosis clinical isolates from Brazil and Turkey
por: Daneshnia, Farnaz, et al.
Publicado: (2022)

P027 Early warning bells: emergence of fluconazole resistance in Candida parapsilosis
por: Ajapuje, Preeti
Publicado: (2022)

Fluconazole-resistant Candida parapsilosis: A new emerging threat in the fungi arena
por: Escribano, Pilar, et al.
Publicado: (2022)

Candida haemulonii Complex Species, Brazil, January 2010–March 2015
por: Nobrega de Almeida, João, et al.
Publicado: (2016)

The Effect on Mortality of Fluconazole or Echinocandins Treatment in Candidemia in Internal Medicine Wards
por: De Rosa, Francesco G., et al.
Publicado: (2015)

Impact of the Disk Diffusion Test on Fluconazole De-Escalation in Patients with Candidemia
por: Tantasuwan, Suchavadee, et al.
Publicado: (2022)

Candidemia among Hospitalized Pediatric Patients Caused by Several Clonal Lineages of Candida parapsilosis
por: Hare, Rasmus Krøger, et al.
Publicado: (2022)

2117. Fluconazole vs. Echinocandins as Initial Therapy for Candidemia Caused by Fluconazole-Susceptible Species in the Era of Rapid Diagnostic Testing
por: Roshdy, Danya, et al.
Publicado: (2019)

Correction: The Effect on Mortality of Fluconazole or Echinocandins Treatment in Candidemia in Internal Medicine Wards
Publicado: (2015)

Clonal Candidemia Outbreak by Candida parapsilosis Carrying Y132F in Turkey: Evolution of a Persisting Challenge
por: Arastehfar, Amir, et al.
Publicado: (2021)

Systemic Candida parapsilosis Infection Model in Immunosuppressed ICR Mice and Assessing the Antifungal Efficiency of Fluconazole
por: Wu, Yu'e, et al.
Publicado: (2015)

Incidence of candidemia before and after fluconazole prophylaxis implementation in a 14-bed general ICU
por: Vartzeli, P, et al.
Publicado: (2008)

Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients
por: Grau, S, et al.
Publicado: (2015)

Epidemiology of Candidemia and Fluconazole Resistance in an ICU before and during the COVID-19 Pandemic Era
por: Routsi, Christina, et al.
Publicado: (2022)

Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia
por: Gebretekle, Gebremedhin Beedemariam, et al.
Publicado: (2022)

Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies
por: Moreno-García, E, et al.
Publicado: (2021)

Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China
por: Ning, Yating, et al.
Publicado: (2022)

P019 A 5-year study on prevalence and molecular determinants of fluconazole -resistance in C. parapsilosis spp. complex
por: Sharma, Vrinda, et al.
Publicado: (2022)

Correction to: Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies
por: Moreno-García, E, et al.
Publicado: (2022)

357. Risk Factors and Antifungal Susceptibility Pattern of Candida parapsilosis Candidemia: A Single centre Observation study from Central India.
por: Garg, Rahul, et al.
Publicado: (2022)

Species Distribution of Candidemia and Their Susceptibility in a Single Japanese University Hospital: Prior Micafungin Use Affects the Appearance of Candida parapsilosis and Elevation of Micafungin MICs in Non-parapsilosis Candida Species
por: Sakamoto, Yasutaka, et al.
Publicado: (2021)

Global Emergence of Resistance to Fluconazole and Voriconazole in Candida parapsilosis in Tertiary Hospitals in Spain During the COVID-19 Pandemic
por: Trevijano-Contador, Nuria, et al.
Publicado: (2022)

Fluconazole-Resistant Candida parapsilosis Bloodstream Isolates with Y132F Mutation in ERG11 Gene, South Korea
por: Choi, Yong Jun, et al.
Publicado: (2018)

Draft Genome Sequence of a Fluconazole-Resistant Candida auris Strain from a Candidemia Patient in India
por: Sharma, Cheshta, et al.
Publicado: (2015)

Outcomes Comparing Initial Short vs Long Course Echinocandin Therapy in Patients with Candidemia Caused by Fluconazole Susceptible Strains
por: Small-Saunders, Jennifer L, et al.
Publicado: (2017)

Evaluation of the early fluconazole treatment of candidemia protocol with automated short message service alerts: a before-and-after study
por: Yoo, Jeong Rae, et al.
Publicado: (2021)

Cm-p5 Peptide Dimers Inhibit Biofilms of Candida albicans Clinical Isolates, C. parapsilosis and Fluconazole-Resistant Mutants of C. auris
por: Amann, Valerie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fos01sfl77vepbjbsphljg1co0